Iliac Stent Market Size was valued at USD 1.02 Bn in 2023 and is predicted to reach USD 1.61 Bn by 2031 at a 6.07% CAGR during the forecast period for 2024-2031.
The iliac artery is one of the main pelvic arteries that supplies blood to the lower limbs. An iliac stent, a small tube device made of steel mesh, is designed to be implanted into this artery. Factors responsible for propelling the market for iliac stent diseases including technological developments in stents, an increase in angioplasty operations, a rise in the need for less intrusive operations, and the aging of the population. In addition, there are anticipated growth prospects for market players in the coming years due to the development of iliac stent materials and expansion into emerging markets. In addition, the market’s growth is anticipated to be hindered during the forecast period by the presence of alternative treatment techniques for cardiac illnesses, strict rules for product approval, and many product failures and recalls. Rising demand is further supported by the expanding recognition of iliac stenting’s advantages over other therapies, both among patients and healthcare providers. This will also drive the market growth in the coming years.
However, the market growth is hindered by obstacles such as problems occurring during the stenting process, the possibility of product failure, and the strict regulatory standards for the clearance of medical equipment. Global markets expanded during the coming years due to technological developments, and iliac stents are in high demand, increasing the prevalence of peripheral arterial disorders.
The iliac stent market is segmented based on type, artery lesions, and end-use. Based on type, the market is segmented into self-expandable stents, balloon-expandable stents, and others. By artery lesions, the market is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. By end-use, the market is segmented into hospitals, outpatient facilities, and others.
The self-expandable stents iliac stent market is expected to hold a significant global market share in 2022 because a self-expandable stent can widen and retain open the constricted or obstructed iliac arteries, allowing blood to flow freely to the lower extremities again. Leg pain, cramps, and numbness, signs of iliac artery occlusive disease, will go away with this. Additionally, the long-term patency of the treated artery can be better maintained using self-expandable iliac stents because they are made from robust materials. Positive results from long-term clinical studies are also likely to boost healthcare practitioners’ confidence.
The common iliac artery lesions segment is projected to grow rapidly in the global iliac stent market because a common iliac artery lesion is an abnormality or condition affecting the arteries that branch off the aorta and provide blood to the lower extremities and pelvis. The iliac arteries can develop various diseases, including atherosclerosis, stenosis, aneurysms, dissection, etc. Because obesity and high cholesterol both lead to plaque development, which restricts or clogs the artery lumen, the rising number of patients with these disorders is likely to increase the demand for iliac stents in this segment.
The North American iliac stent market is anticipated to register the highest market share in revenue in the near future. This can be attributed to drivers driving market expansion, including rising disease awareness, increased research and development for novel medicines, and the prevalence of arterial diseases. In addition, Asia Pacific is projected to fastest growing region in the markets because several factors are propelling the iliac stents market in this area, including the rising prevalence of cardiovascular disease in developing nations like China and India and the aging population in industrialized nations. Furthermore, the rising need for less intrusive treatments, the improvement of healthcare facilities, the expansion of insurance policies, and the growing public knowledge of peripheral artery disease all contribute to this industry's growth.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.02 Bn |
|
Revenue Forecast In 2031 |
USD 1.61 Bn |
|
Growth Rate CAGR |
CAGR of 6.07% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, By Artery Lesions, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
BD, Abbott, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Medtronic, Cook, Terumo Corporation, iVascular, Getinge AB and Biotronik SE & Co KG |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Iliac Stents Market Snapshot
Chapter 4. Global Iliac Stents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Self-expandable Stents
5.2.2. Balloon-expandable Stents
5.2.3. Others
Chapter 6. Market Segmentation 2: by Artery Lesions Estimates & Trend Analysis
6.1. by & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Artery Lesions:
6.2.1. Common Iliac Artery Lesions
6.2.2. Severe Calcified Lesions
6.2.3. Complete Obstructive Lesions
Chapter 7. Market Segmentation 3: by End-Use Estimates & Trend Analysis
7.1. by End-Use & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-Use:
7.2.1. Hospitals
7.2.2. Outpatient Facilities
7.2.3. Others
Chapter 8. Iliac Stents Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.1.2. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.1.3. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.1.4. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.2.2. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.2.3. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.2.4. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.3.2. Asia-Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.3.3. Asia Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.3.4. Asia Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.4.2. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.4.3. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.4.4. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.5.2. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.5.3. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.5.4. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. Alvimedica
9.2.3. B. Braun SE
9.2.4. Becton, Dickinson and Company
9.2.5. Biotronik SE & Co KG
9.2.6. Boston Scientific Corporation
9.2.7. Cook Medical
9.2.8. Getinge AB
9.2.9. iVascular
9.2.10. Medtronic Plc
9.2.11. Terumo Corporation
9.2.12. W. L. Gore & Associates, Inc.
9.2.13. Other Prominent Players
Iliac Stent Market-By Type
Iliac Stent Market-By Artery Lesions
Iliac Stent Market-By End-Use
Iliac Stent Market-By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
